Volume 134, Issue 7, Pages e3 (June 2008)

Slides:



Advertisements
Similar presentations
Third-party Mesenchymal Stem Cells Improved Human Islet Transplantation in a Humanized Diabetic Mouse Model  Hao Wu, Di Wen, Ram I Mahato  Molecular Therapy 
Advertisements

Volume 142, Issue 3, Pages (March 2012)
Volume 140, Issue 3, Pages e4 (March 2011)
Mice With Human Livers Gastroenterology
Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
Zhao Jing, M. D. , Zhang Qiong, M. D. , Wang Yonggang, M. D
Volume 140, Issue 3, Pages e4 (March 2011)
Volume 131, Issue 1, Pages (July 2006)
Volume 134, Issue 7, Pages e3 (June 2008)
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Volume 133, Issue 2, Pages (August 2007)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 142, Issue 5, Pages e3 (May 2012)
Volume 144, Issue 7, Pages e10 (June 2013)
Volume 140, Issue 3, Pages e4 (March 2011)
Outcomes Among Living Liver Donors
This Month in Gastroenterology
This Month in Gastroenterology
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 138, Issue 7, Pages e7 (June 2010)
Volume 137, Issue 4, Pages e5 (October 2009)
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation  Lucrezia Colonna, Mareike.
Volume 131, Issue 1, Pages (July 2006)
Volume 142, Issue 3, Pages (March 2012)
Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
Volume 138, Issue 2, Pages e2 (February 2010)
Volume 3, Issue 5, Pages (November 2014)
Volume 18, Issue 10, Pages (October 2010)
Volume 139, Issue 4, Pages e5 (October 2010)
Volume 132, Issue 7, Pages (June 2007)
Volume 145, Issue 4, Pages e10 (October 2013)
Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases  Chien-Wei Lee, Yu-Fan Chen, Hao-Hsiang Wu,
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 140, Issue 7, Pages e2 (June 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 144, Issue 2, Pages (February 2013)
This Month in Gastroenterology
Volume 142, Issue 2, Pages (February 2012)
Treatment of Hypohepatia After Transplantation of Liver From a Living Donor Liver by Transcatheter Embolization, Using a Simulated 3-Dimensional Printing.
Volume 143, Issue 6, Pages e2 (December 2012)
An Unusual Case Presented With Multiple Liver Cystic Lesions
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 132, Issue 1, Pages (January 2007)
Third-party Mesenchymal Stem Cells Improved Human Islet Transplantation in a Humanized Diabetic Mouse Model  Hao Wu, Di Wen, Ram I Mahato  Molecular Therapy 
Volume 134, Issue 3, Pages (March 2008)
Volume 140, Issue 3, Pages e4 (March 2011)
Volume 134, Issue 7, Pages e3 (June 2008)
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Volume 15, Issue 6, Pages (June 2007)
Volume 140, Issue 3, Pages (March 2011)
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Volume 139, Issue 2, Pages e1 (August 2010)
Volume 64, Issue 5, Pages (May 2016)
The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
Volume 19, Issue 1, Pages (January 2011)
Volume 133, Issue 2, Pages (August 2007)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher 
Volume 140, Issue 7, Pages e2 (June 2011)
Volume 140, Issue 3, Pages e4 (March 2011)
Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells  Christian Scheffold, Yolanda C. Scheffold,
Volume 4, Issue 2, Pages (February 2009)
Covering the Cover Gastroenterology
Volume 5, Issue 1, Pages (July 2009)
Volume 2, Issue 1, Pages (January 2008)
Siddharth Singh, Matthew T. Howard, Konstantinos A. Papadakis 
Volume 18, Issue 8, Pages (August 2010)
Volume 124, Issue 7, Pages (June 2003)
A Female Patient With Persistent Epigastric Pain for 1 Week
Presentation transcript:

Volume 134, Issue 7, Pages 2111-2121.e3 (June 2008) Stem Cell Therapy for Liver Disease: Parameters Governing the Success of Using Bone Marrow Mesenchymal Stem Cells  Tom K. Kuo, Shun–Pei Hung, Chiao–Hui Chuang, Chien–Tsun Chen, Yu–Ru V. Shih, Szu–Ching Y. Fang, Vincent W. Yang, Oscar K. Lee  Gastroenterology  Volume 134, Issue 7, Pages 2111-2121.e3 (June 2008) DOI: 10.1053/j.gastro.2008.03.015 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 MDHs and MSCs rescue lethal FHF. (A) Effect of CCl4 on NOD-SCID mice survival at 0.2–0.4 mL/kg administered by gavage. Survival curves of NOD-SCID mice that underwent intrasplenic transplantation with 1.4 × 106 to 4.2 × 107/kg of (B) MDHs and (C) MSCs and intravenous transplantation with 1.4 × 106 to 4.2 × 107/kg of (D) MDHs and (E) MSCs at 24 hours after administration of 0.28 ml/kg CCl4. Statistical analysis was performed by log-rank test (intrasplenic MSC vs intrasplenic MDH: 4.2 × 107/kg, P = .0001; 1.4 × 107/kg, P = .0018; 4.2 × 106/kg, P = .0190; 1.4 × 106/kg, P = .0190; intravenous MSC vs intravenous MDH: 4.2 × 107/kg, P = .1380; 1.4 × 107/kg, P = .0190; 4.2 × 106/kg, P = .0047; 1.4 × 106/kg, P = .0009). Gastroenterology 2008 134, 2111-2121.e3DOI: (10.1053/j.gastro.2008.03.015) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Transplanted donor cells engraft recipient liver and differentiate into hepatocytes. (A) FACS for human B2M-expressing cells at 4 weeks posttransplantation of MSCs (MSC-Tx). Human B2M-sorted cells (hB2M+) were (B) analyzed for expression of liver marker genes by Western blot and (C) verified for their human origin by genomic DNA polymerase chain reaction. (D) Detection of human albumin in the peripheral blood of recipients rescued by MSC transplantation (enzyme-linked immunosorbent assay, mean ± SD of 3 determinations). Gastroenterology 2008 134, 2111-2121.e3DOI: (10.1053/j.gastro.2008.03.015) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 MSCs are more resistant to oxidative stress than MDHs. Effect of exogenous oxidant (A) paraquat and (B) hydrogen peroxide on the viability of MSCs and MDHs (mean ± SD of 3 determinations). (C) Basal expression of antioxidative enzymes in MSCs and MDHs by Western blot. CuZnSOD, copper/zinc superoxide dismutase; MnSOD, manganese superoxide dismutase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. >Change in expression of antiapoptotic genes (D) Bcl-2 and (E) Bcl-xL in MSCs and MDHs in the presence of exogenous oxidant paraquat (mean ± SD of 3 determinations). (F) Changes in reduced glutathione/oxidized glutathione ratio in mice that underwent transplantation with MSCs and MDHs at 24 hours after administration of 0.28 mL CCl4/kg (mean ± SD of 3 determinations). Statistical analysis was performed by paired t test; P < .05 was considered significant. *Statistical significance (D–F). Gastroenterology 2008 134, 2111-2121.e3DOI: (10.1053/j.gastro.2008.03.015) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 Transplantation of MSCs rescues endogenous hepatocytes. (A) Mean percentage of necrosis in the liver of recipient mice that underwent transplantation with MSCs and MDHs at 3 and 6 days after CCl4 administration (mean ± SD of 10 determinations). (B) Change in the number of donor-derived cells in the liver of recipient mice that underwent transplantation with MSCs and MDHs at 3, 5, and 7 days after CCl4 administration (mean ± SD of 3 determinations). Bromodeoxyuridine incorporation in the liver of (C) MSC recipients and (D) MDH recipients at 3 and 5 days after CCl4 administration (red arrowheads, QuantumDot-labeled donor cells; blue, nuclei staining; brown nuclei, bromodeoxyuridine-labeled cells). (E) Effect of MSC and MDH coculture on the proliferation of hepatocytes after paraquat treatment (mean ± SD of 3 determinations). Statistical analysis was performed by paired t test; P < .05 was considered significant. *Statistical significance (A,B,E). Gastroenterology 2008 134, 2111-2121.e3DOI: (10.1053/j.gastro.2008.03.015) Copyright © 2008 AGA Institute Terms and Conditions